NASDAQ : SRPT
Sarepta Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 18.625 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.97B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Sarepta Therapeutics, Inc. (SRPT) reported revenue of 1.97B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.97B | 2.20B | 1.90B | 1.24B | 933.01M | 701.89M |
| Cost of Revenue | 1.60B | 2.36B | 1.12B | 1.03B | 1.02B | 862.13M |
| Gross Profit | 377.26M | -163.43M | 778.36M | 215.61M | -84.07M | -160.24M |
| Selling, General & Admin | 436.74M | 491.72M | 557.87M | 481.87M | 451.42M | 282.66M |
| Amortization of Goodwill & Intangibles | 2.76M | 2.62M | 2.40M | 1.56M | 714.00K | 706.00K |
| Operating Expenses | 439.50M | 494.34M | 560.28M | 483.43M | 452.13M | 283.37M |
| Operating Income | -62.24M | -657.77M | 218.08M | -267.82M | -536.20M | -443.61M |
| Interest Expense | -71.63M | -38.14M | -18.39M | -22.01M | -53.25M | -63.52M |
| Interest & Investment Income | 27.89M | 30.76M | 30.64M | 36.26M | 16.49M | 354.00K |
| Other Non Operating Income (Expenses) | -122.00K | -1.94M | -60.00K | -910.00K | -6.92M | -936.00K |
| EBT Excluding Unusual Items | -106.11M | -667.09M | 230.26M | -254.49M | -579.88M | -507.72M |
| Merger & Restructuring Charges | -42.01M | -42.01M | ||||
| Gain (Loss) on Sale of Investments | 39.33M | -9.99M | 38.35M | 20.92M | 8.66M | -4.33M |
| Gain (Loss) on Sale of Assets | 102.00M | 102.00M | ||||
| Other Unusual Items | 16.86M | 16.86M | -7.84M | -388.53M | -118.74M | -8.90M |
| Pretax Income | -130.92M | -702.23M | 260.77M | -520.10M | -689.96M | -418.95M |
| Income Tax Expense | 5.80M | 11.19M | 25.54M | 15.88M | 13.53M | -168.00K |
| Net Income | -136.72M | -713.41M | 235.24M | -535.98M | -703.49M | -418.78M |
| Net Income to Common | -136.72M | -713.41M | 235.24M | -535.98M | -703.49M | -418.78M |
| Shares Outstanding (Basic) | 103.88M | 100.12M | 95.08M | 92.40M | 87.56M | 81.26M |
| Shares Outstanding (Diluted) | 103.88M | 100.12M | 107.88M | 92.40M | 87.56M | 81.26M |
| EPS (Basic) | -1.32 | -7.13 | 2.47 | -5.80 | -8.03 | -5.15 |
| EPS (Diluted) | -1.32 | -7.13 | 2.34 | -5.80 | -8.03 | -5.15 |
| Free Cash Flow | 81.85M | -307.45M | -342.74M | -577.10M | -356.17M | -481.66M |
| Free Cash Flow Per Share | 0.79 | -3.07 | -3.18 | -6.25 | -4.07 | -5.93 |
| Gross Margin | 19.11% | -7.43% | 40.92% | 17.34% | -9.01% | -22.83% |
| Operating Margin | -3.15% | -29.92% | 11.47% | -21.54% | -57.47% | -63.20% |
| Profit Margin | -6.93% | -32.45% | 12.37% | -43.11% | -75.40% | -59.66% |
| Free Cash Flow Margin | 4.15% | -13.99% | -18.02% | -46.41% | -38.17% | -68.62% |
| EBITDA | -17.53M | -613.25M | 255.81M | -223.43M | -494.34M | -405.59M |
| EBITDA Margin | -0.89% | -27.90% | 13.45% | -17.97% | -52.98% | -57.79% |
| D&A For EBITDA | 44.71M | 44.52M | 37.72M | 44.40M | 41.86M | 38.02M |
| EBIT | -62.24M | -657.77M | 218.08M | -267.82M | -536.20M | -443.61M |
| EBIT Margin | -3.15% | -29.92% | 11.47% | -21.54% | -57.47% | -63.20% |
| Effective Tax Rate | 9.79% | |||||
| Revenue as Reported | 1.97B | 2.20B | 1.90B | 1.24B | 933.01M | 701.89M |
| Advertising Expenses | 29.50M | 32.00M | 28.60M | 14.60M | 7.70M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 571.15M | 801.28M | 1.10B | 428.43M | 966.78M | 2.12B |
| Short-Term Investments | 217.34M | 138.37M | 251.78M | 1.25B | 1.02B | |
| Cash & Short-Term Investments | 788.49M | 939.65M | 1.35B | 1.68B | 1.99B | 2.12B |
| Accounts Receivable | 421.84M | 502.35M | 636.60M | 430.11M | 256.39M | 171.64M |
| Other Receivables | 16.97M | 17.26M | 15.10M | 6.86M | 5.21M | 8.00K |
| Receivables | 438.81M | 519.61M | 651.70M | 436.98M | 261.60M | 171.65M |
| Inventory | 904.27M | 914.74M | 749.96M | 322.86M | 203.97M | 186.21M |
| Prepaid Expenses | 29.04M | 29.24M | 32.88M | 27.64M | 29.64M | 30.31M |
| Other Current Assets | 63.21M | 134.69M | 284.13M | 115.61M | 73.28M | 100.06M |
| Total Current Assets | 2.22B | 2.54B | 3.07B | 2.58B | 2.56B | 2.60B |
| Property, Plant & Equipment | 446.84M | 470.62M | 488.65M | 357.11M | 244.99M | 236.69M |
| Long-Term Investments | 151.72M | 10.57M | 136.87M | 6.53M | 31.32M | 34.89M |
| Other Intangible Assets | 30.61M | 28.95M | 26.89M | 29.62M | 7.58M | 14.24M |
| Long-Term Deferred Tax Assets | 2.86M | 2.82M | 2.25M | |||
| Other Long-Term Assets | 332.66M | 298.81M | 235.05M | 291.99M | 286.62M | 258.06M |
| Total Assets | 3.19B | 3.35B | 3.96B | 3.26B | 3.13B | 3.15B |
| Accounts Payable | 50.98M | 280.84M | 214.44M | 164.92M | 95.88M | 76.74M |
| Accrued Expenses | 158.28M | 237.39M | 246.97M | 197.93M | 335.67M | 206.45M |
| Current Portion of Long-Term Debt | 105.48M | |||||
| Current Portion of Leases | 16.56M | 11.20M | 15.49M | |||
| Current Income Taxes Payable | 9.31M | 4.75M | 17.39M | 13.77M | 12.52M | 216.00K |
| Current Unearned Revenue | 110.13M | 443.40M | 130.26M | 50.42M | 89.24M | 89.24M |
| Other Current Liabilities | 157.64M | 117.72M | 122.63M | 121.15M | 70.80M | 80.08M |
| Total Current Liabilities | 502.91M | 1.10B | 731.68M | 653.66M | 619.60M | 452.73M |
| Long-Term Debt | 847.62M | 828.97M | 1.14B | 1.13B | 1.54B | 1.10B |
| Long-Term Leases | 198.23M | 199.38M | 192.47M | 140.97M | 57.58M | 41.51M |
| Long-Term Unearned Revenue | 110.13M | 83.91M | 325.00M | 437.00M | 485.00M | 574.24M |
| Other Long-Term Liabilities | 1.82M | 1.53M | 49.15M | 41.10M | 36.94M | 54.60M |
| Total Liabilities | 1.66B | 2.21B | 2.44B | 2.41B | 2.74B | 2.22B |
| Common Stock | 11.00K | 11.00K | 10.00K | 9.00K | 9.00K | 9.00K |
| Additional Paid-In Capital | 6.10B | 6.04B | 5.74B | 5.30B | 4.30B | 4.13B |
| Retained Earnings | -4.55B | -4.88B | -4.21B | -4.45B | -3.91B | -3.21B |
| Treasury Stock | -25.26M | -25.26M | ||||
| Comprehensive Income & Other | -565.00K | 272.00K | -218.00K | 918.00K | -1.66M | -20.00K |
| Shareholders' Equity | 1.53B | 1.14B | 1.53B | 859.34M | 384.95M | 928.01M |
| Total Liabilities & Equity | 3.19B | 3.35B | 3.96B | 3.26B | 3.13B | 3.15B |
| Total Debt | 1.06B | 1.04B | 1.33B | 1.38B | 1.62B | 1.14B |
| Net Cash (Debt) | -273.92M | -99.90M | 25.20M | 297.29M | 372.01M | 977.48M |
| Net Cash Per Share | -2.64 | -1.00 | 0.23 | 3.22 | 4.25 | 12.03 |
| Filing Date Shares Outstanding | 105.63M | 104.99M | 97.03M | 93.86M | 87.98M | 87.15M |
| Total Common Shares Outstanding | 105.62M | 104.96M | 96.90M | 93.73M | 87.95M | 87.13M |
| Working Capital | 1.72B | 1.44B | 2.34B | 1.93B | 1.94B | 2.15B |
| Book Value Per Share | 14.46 | 10.87 | 15.77 | 9.17 | 4.38 | 10.65 |
| Tangible Book Value | 1.50B | 1.11B | 1.50B | 829.72M | 377.37M | 913.77M |
| Tangible Book Value Per Share | 14.17 | 10.59 | 15.49 | 8.85 | 4.29 | 10.49 |
| Land | 10.17M | 10.17M | 10.17M | 5.18M | 5.18M | |
| Buildings | 52.23M | 51.18M | 48.06M | 47.94M | 47.60M | |
| Machinery | 152.98M | 141.98M | 118.63M | 102.31M | 75.04M | |
| Construction In Progress | 5.58M | 165.90M | 91.09M | 23.59M | 25.16M | |
| Leasehold Improvements | 349.73M | 155.07M | 99.99M | 97.33M | 103.37M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -136.72M | -713.41M | 235.24M | -535.98M | -703.49M | -418.78M |
| Depreciation & Amortization | 44.71M | 44.52M | 37.72M | 44.40M | 41.86M | 38.02M |
| Loss (Gain) From Sale of Assets | -102.00M | -102.00M | ||||
| Loss (Gain) From Sale of Investments | -37.50M | 12.00M | -40.28M | -15.86M | -8.08M | 4.39M |
| Stock-Based Compensation | 98.81M | 123.40M | 184.30M | 182.51M | 233.02M | 113.94M |
| Other Operating Activities | 274.34M | 249.97M | 93.83M | 407.02M | 150.81M | 19.43M |
| Change in Accounts Receivable | 150.47M | 203.75M | -201.66M | -185.70M | -61.64M | -51.65M |
| Change in Inventory | -94.39M | -301.09M | -395.17M | -147.71M | -50.78M | -83.77M |
| Change in Accounts Payable | -47.85M | 104.27M | 110.65M | -50.13M | 147.57M | 23.30M |
| Change in Unearned Revenue | -175.17M | 72.05M | -32.16M | -86.83M | -89.24M | -89.24M |
| Change in Other Net Operating Assets | 34.31M | -944.00K | -198.26M | -10.71M | 14.62M | 103.20M |
| Operating Cash Flow | 111.01M | -205.48M | -205.79M | -500.99M | -325.35M | -443.17M |
| Capital Expenditures | -29.16M | -101.97M | -136.96M | -76.11M | -30.82M | -38.49M |
| Sale (Purchase) of Intangibles | -6.88M | -7.88M | -10.00M | 90.76M | -1.43M | 99.69M |
| Investment in Securities | 136.88M | 179.49M | 902.52M | -180.46M | -1.01B | 434.21M |
| Investing Cash Flow | 100.84M | 69.64M | 755.56M | -165.80M | -1.05B | 495.41M |
| Long-Term Debt Issued | 1.13B | |||||
| Long-Term Debt Repaid | -162.59M | -68.00K | -823.23M | |||
| Net Debt Issued (Repaid) | -159.07M | -162.59M | -68.00K | 304.17M | ||
| Issuance of Common Stock | 21.76M | 38.70M | 79.53M | 51.25M | 30.04M | 569.33M |
| Repurchase of Common Stock | -25.01M | -7.76M | ||||
| Other Financing Activities | -19.45M | -19.45M | 45.35M | 73.76M | -101.70M | |
| Financing Cash Flow | -156.76M | -168.34M | 124.81M | 125.00M | 232.51M | 561.57M |
| Net Cash Flow | 55.10M | -304.18M | 674.58M | -541.79M | -1.14B | 613.81M |
| Free Cash Flow | 81.85M | -307.45M | -342.74M | -577.10M | -356.17M | -481.66M |
| Free Cash Flow Margin | 4.15% | -13.99% | -18.02% | -46.41% | -38.17% | -68.62% |
| Free Cash Flow Per Share | 0.79 | -3.07 | -3.18 | -6.25 | -4.07 | -5.93 |
| Levered Free Cash Flow | 22.14M | 95.92M | -432.21M | -330.11M | -54.65M | -8.70M |
| Unlevered Free Cash Flow | 66.91M | 119.75M | -420.71M | -316.36M | -21.37M | 31.01M |
| Cash Interest Paid | 31.77M | 14.91M | 15.86M | 15.92M | 44.42M | 55.95M |
| Cash Income Tax Paid | 27.01M | 37.63M | 22.59M | 15.08M | 1.70M | 583.00K |
| Change in Working Capital | -132.63M | 78.04M | -716.61M | -481.09M | -39.47M | -98.17M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.94B | 2.26B | 11.61B | 9.02B | 11.37B | 7.84B |
| Enterprise Value | 2.22B | 2.66B | 11.83B | 8.68B | 10.91B | 7.42B |
| Last Close Price | 18.62 | 21.52 | 121.59 | 96.43 | 129.58 | 90.05 |
| PE Ratio | 49.37 | |||||
| Forward PE | 81.49 | 90.12 | 15.47 | |||
| PS Ratio | 1.00 | 1.03 | 6.11 | 7.25 | 12.19 | 11.17 |
| PB Ratio | 1.29 | 1.98 | 7.60 | 10.50 | 29.55 | 8.45 |
| P/TBV Ratio | 1.32 | 2.03 | 7.74 | 10.87 | 30.14 | 8.58 |
| PEG Ratio | 7.48 | |||||
| EV/Sales Ratio | 1.14 | 1.21 | 6.22 | 6.98 | 11.69 | 10.57 |
| EV/EBITDA Ratio | 46.25 | |||||
| EV/EBIT Ratio | 54.25 | |||||
| Debt / Equity Ratio | 0.69 | 0.91 | 0.87 | 1.60 | 4.20 | 1.23 |
| Debt / EBITDA Ratio | 7.07 | 3.70 | ||||
| Debt / FCF Ratio | 12.98 | |||||
| Net Debt / Equity Ratio | 0.18 | 0.09 | -0.02 | -0.35 | -0.97 | -1.05 |
| Net Debt / EBITDA Ratio | -15.62 | -0.16 | -0.10 | 1.33 | 0.75 | 2.41 |
| Net Debt / FCF Ratio | 3.35 | -0.33 | 0.07 | 0.52 | 1.04 | 2.03 |
| Asset Turnover | 0.57 | 0.60 | 0.53 | 0.39 | 0.30 | 0.23 |
| Inventory Turnover | 1.68 | 2.84 | 2.10 | 3.90 | 5.21 | 4.12 |
| Quick Ratio | 2.44 | 1.33 | 2.74 | 3.23 | 3.63 | 5.05 |
| Current Ratio | 4.42 | 2.32 | 4.20 | 3.95 | 4.13 | 5.75 |
| Return on Equity (ROE) | -9.48% | -53.47% | 19.71% | -86.15% | -107.16% | -49.57% |
| Return on Assets (ROA) | -1.13% | -11.24% | 3.77% | -5.24% | -10.68% | -9.04% |
| Return on Invested Capital (ROIC) | -3.36% | -47.96% | 19.06% | -47.65% | ||
| Return on Capital Employed (ROCE) | -2.30% | -29.20% | 6.70% | -10.30% | -21.40% | -16.50% |
| Earnings Yield | -7.15% | -31.64% | 2.02% | -5.94% | -6.19% | -5.34% |
| FCF Yield | 4.16% | -13.63% | -2.95% | -6.40% | -3.13% | -6.14% |
| Buyback Yield / Dilution | -7.36% | 7.19% | -16.75% | -5.53% | -7.75% | -4.24% |